Athira Pharma
ATHA
ATHA
56 hedge funds and large institutions have $10.5M invested in Athira Pharma in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 20 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
70% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 20
Holders
56
Holding in Top 10
–
Calls
$12K
Puts
$2K
Top Buyers
| 1 | +$1.63M | |
| 2 | +$168K | |
| 3 | +$102K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$44.1K |
| 5 |
HF
HRT Financial
New York
|
+$25K |
Top Sellers
| 1 | -$144K | |
| 2 | -$143K | |
| 3 | -$115K | |
| 4 |
Pathstone Holdings
Englewood,
New Jersey
|
-$70.4K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$59K |